FDA Approves Oral Treatment for Postpartum Depression
Striking Pharmacists Put Concern for Patients First
Swipe Right on Wellness: The Rise of Digital Therapeutics in Mental Health
Should Pharmacists Conduct Mental Health Evaluations?
OTC Product Roundup: Allergies
Chronic Pain and Mental Health: A Compounding Relationship
How Pharmacists Are Expanding Reproductive Care Access
The Psychedelic Pharmacy: A Paradigm Shift in Mental Health Treatment
Consumer Survey Data Show Opportunity, Challenges in OTC Space
High Frequency of OTC Product Misuse in Older Adults Highlights Areas for Pharmacists to Address
How "Scope Creep" Can Save Health Care
FDA Approves Resmetirom as First-Ever Treatment For MASH
Boehringer Ingelheim to Cap Out of Pocket Inhaler Costs at $35 Per Month
FDA Grants Breakthrough Therapy Designation to LSD-Based Treatment for Generalized Anxiety Disorder
Breaking: FDA Clears Dexcom Stelo, First OTC Continuous Glucose Monitor